French pharmaceutical firm Sanofi yesterday said it is partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments.
The titan in online search “will apply technology and analytics on Sanofi’s large real world database to better understand what treatments work for patients,” the pharmaceutical firm said in a statement.
The use of Google’s tools for deep analytics — organizing large amounts of data to gain insights — will help it better understand key diseases and patient outcomes to make further improvements.
Sanofi would also be moving some of its business applications to Google’s cloud computing platform and use artificial intelligence to improve operations.
“Combining Sanofi’s biologic innovations and scientific data with Google’s industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies,” said Ameet Nathwani, who is Sanofi’s chief digital officer in addition to being its chief medical officer and executive vice president.
Sanofi, which made 34.5 billion euros (US$38.8 billion) of sales last year, is a major manufacturer of vaccines, insulin, cancer treatments and cardiovascular drugs.
Sanofi did not mention any financial figures related to the deal with Google, but trade unions are concerned that the firm may announce cuts in research and development at a meeting scheduled for yesterday.
It is not Sanofi’s first collaboration with Alphabet Inc, which is the parent company of Google. Last month, Alphabet’s health division Verily announced partnerships with four major pharmaceutical firms, including Sanofi, to accelerate clinical testing using digital technologies.
Sanofi and Verily also created in 2016 a joint venture, Onduo, to develop connected devices to improve diabetes care.
Vincent Wei led fellow Singaporean farmers around an empty Malaysian plot, laying out plans for a greenhouse and rows of leafy vegetables. What he pitched was not just space for crops, but a lifeline for growers struggling to make ends meet in a city-state with high prices and little vacant land. The future agriculture hub is part of a joint special economic zone launched last year by the two neighbors, expected to cost US$123 million and produce 10,000 tonnes of fresh produce annually. It is attracting Singaporean farmers with promises of cheaper land, labor and energy just over the border.
US actor Matthew McConaughey has filed recordings of his image and voice with US patent authorities to protect them from unauthorized usage by artificial intelligence (AI) platforms, a representative said earlier this week. Several video clips and audio recordings were registered by the commercial arm of the Just Keep Livin’ Foundation, a non-profit created by the Oscar-winning actor and his wife, Camila, according to the US Patent and Trademark Office database. Many artists are increasingly concerned about the uncontrolled use of their image via generative AI since the rollout of ChatGPT and other AI-powered tools. Several US states have adopted
A proposed billionaires’ tax in California has ignited a political uproar in Silicon Valley, with tech titans threatening to leave the state while California Governor Gavin Newsom of the Democratic Party maneuvers to defeat a levy that he fears would lead to an exodus of wealth. A technology mecca, California has more billionaires than any other US state — a few hundred, by some estimates. About half its personal income tax revenue, a financial backbone in the nearly US$350 billion budget, comes from the top 1 percent of earners. A large healthcare union is attempting to place a proposal before
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
RSS